David Weill serves as Executive at TransMedics Group, Inc., where they oversee executive responsibilities. Since joining the company, David Weill has executed 13 insider transactions totaling $3.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 3, 2025 involved selling 5,000 shares valued at $693.2K.
David Weill currently holds 12,134 shares of TransMedics Group, Inc. (TMDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Weill has been a net seller of TMDX stock. They have purchased $325.0K and sold $2.9M worth of shares.
David Weill's most recent insider trade was on Dec 3, 2025, when they sold 5,000 shares at $138.64 per share.
Get notified when new Form 4 filings are submitted
| $14.20 |
| Discretionary |
| May 29, 2024 | TMDX | $169.0K | Sale | 1,193 | $141.65 | Discretionary |
| May 23, 2024 | TMDX | $0 | Award | 732 | $N/A | Discretionary |
| May 10, 2024 | TMDX | $324.6K | Sale | 2,500 | $129.82 | Discretionary |
| Aug 29, 2023 | TMDX | $155.0K | Purchase | 2,500 | $62.00 | Discretionary |
| May 25, 2023 | TMDX | $0 | Award | 1,193 | $N/A | Discretionary |
| Feb 27, 2023 | TMDX | $84.3K | Option Exercise | 5,934 | $14.20 | Discretionary |
| Feb 27, 2023 | TMDX | $74.8K | Sale | 964 | $77.64 | Discretionary |
| Feb 27, 2023 | TMDX | $380.3K | Sale | 4,970 | $76.51 | Discretionary |
| Nov 10, 2022 | TMDX | $346.3K | Option Exercise | 21,645 | $16.00 | Discretionary |
| Nov 10, 2022 | TMDX | $1.2M | Sale | 21,645 | $56.00 | Discretionary |
| Nov 11, 2019 | TMDX | $170.0K | Purchase | 10,000 | $17.00 | Discretionary |